These highlights do not include all the information needed to use Novolin R safely and effectively. See full prescribing information for Novolin R.
Novolin ® R (Regular, Human Insulin [rDNA origin] USP) solution for subcutaneous or intravenous use
Initial U.S. Approval: 1991
INDICATIONS AND USAGE
Novolin R is a short-acting recombinant human insulin indicated to improve glycemic control in adults and children with diabetes mellitus (
1).
DOSAGE AND ADMINISTRATION
-
•
-
The dosage and timing of Novolin R must be individualized ( 2.1).
-
•
-
Subcutaneous injection: Administer approximately 30 minutes prior to the start of a meal ( 2.2).
-
•
-
I
